|
US6051397A
(en)
|
1993-11-16 |
2000-04-18 |
Max Planck Gesellschaft Zur Forderung Der Wissenschaften |
DNA encoding MCK-10, a novel receptor tyrosine kinase
|
|
US20020115173A1
(en)
|
2000-12-11 |
2002-08-22 |
Children's Medical Center Corporation |
Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity
|
|
WO2003082328A1
(en)
|
2002-03-12 |
2003-10-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway
|
|
JP2005521420A
(ja)
|
2002-04-03 |
2005-07-21 |
エージーワイ セラピューティクス インコーポレイティッド |
脳腫瘍の処置及び可視化における生体分子標的の使用法
|
|
US20070025997A1
(en)
|
2002-04-03 |
2007-02-01 |
Usha Nagavarapu |
Use of biomolecular targets in the treatment and visualization of brain tumors
|
|
US20100166731A1
(en)
|
2005-09-30 |
2010-07-01 |
Bartz Steven R |
Methods and Compositions for Treating Cancer
|
|
EP1992347A1
(en)
|
2007-05-18 |
2008-11-19 |
Cellzome Ag |
Treatment of DDR1 positive cancer using imatinib
|
|
WO2010019702A2
(en)
*
|
2008-08-12 |
2010-02-18 |
Oncomed Pharmaceuticals, Inc. |
Ddr1-binding agents and methods of use thereof
|
|
CA2780221A1
(en)
|
2009-11-04 |
2011-05-12 |
Fabrus Llc |
Methods for affinity maturation-based antibody optimization
|
|
JP5985481B2
(ja)
|
2010-09-01 |
2016-09-06 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
抗イディオタイプ抗体の迅速な産生
|
|
EP2659269B1
(en)
|
2010-12-23 |
2016-10-26 |
Roche Diagniostics GmbH |
Detection of a posttranslationally modified polypeptide by a bi-valent binding agent
|
|
ES2785081T3
(es)
*
|
2011-04-01 |
2020-10-05 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos biespecíficos similares a receptores de células T específicos para un péptido de WT1 presentado por HLA-A2
|
|
JP6101205B2
(ja)
*
|
2011-08-23 |
2017-03-22 |
中外製薬株式会社 |
抗腫瘍活性を有する新規な抗ddr1抗体
|
|
GB201115529D0
(en)
*
|
2011-09-08 |
2011-10-26 |
Imp Innovations Ltd |
Antibodies, uses and methods
|
|
WO2013113615A1
(en)
|
2012-02-03 |
2013-08-08 |
F. Hoffmann-La Roche Ag |
Bispecific antibody molecules with antigen-transfected t-cells and their use in medicine
|
|
MD20140108A2
(ro)
|
2012-02-29 |
2015-03-31 |
Gilead Biologics, Inc. |
Anticorpi împotriva metaloproteinazei 9 matriciale
|
|
US11873281B2
(en)
|
2012-07-12 |
2024-01-16 |
Hangzhou Dac Biotech Co., Ltd. |
Conjugates of cell binding molecules with cytotoxic agents
|
|
AR092662A1
(es)
*
|
2012-09-24 |
2015-04-29 |
Gilead Sciences Inc |
Anticuerpos anti-ddr1
|
|
WO2014140330A1
(en)
|
2013-03-15 |
2014-09-18 |
Oryzon Genomics, S.A. |
Anti-ddr1 internalizing antibodies and their medical use
|
|
KR102113310B1
(ko)
|
2013-09-03 |
2020-05-20 |
아주대학교 산학협력단 |
암 세포 분리용 조성물, 키트 및 이를 이용한 분리 방법
|
|
US20160251440A1
(en)
|
2013-09-26 |
2016-09-01 |
Ablynx N.V. |
Bispecific nanobodies
|
|
WO2015081127A2
(en)
|
2013-11-26 |
2015-06-04 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
WO2015116569A2
(en)
*
|
2014-01-30 |
2015-08-06 |
Anaptysbio, Inc. |
Antibodies directed against discoidin domain receptor family, member 1 (ddr1)
|
|
CN115414480A
(zh)
|
2014-11-10 |
2022-12-02 |
德玛医药 |
结合放射用于治疗非小细胞肺癌和多形性胶质母细胞瘤的二去水卫矛醇
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
JP2019510752A
(ja)
|
2016-03-04 |
2019-04-18 |
ギリアード サイエンシーズ, インコーポレイテッド |
オートタキシン阻害剤の組成物及び合剤
|
|
KR20180007924A
(ko)
|
2016-07-14 |
2018-01-24 |
주식회사 코리아하이텍 |
차량용 빔프로젝터 방열 장치
|
|
BR112019010002A2
(pt)
*
|
2016-12-16 |
2019-08-20 |
Merck Patent Gmbh |
métodos para o uso de proteína de ligação galectina-3 detectada na urina para monitoramento da gravidade e progressão da nefrite lúpica
|
|
AU2018204986B2
(en)
*
|
2017-01-02 |
2024-08-01 |
The Board Of Regents Of The University Of Texas System |
Anti-LAIR1 antibodies and their uses
|
|
EP3592384B1
(en)
*
|
2017-03-09 |
2025-07-02 |
MAB Discovery GmbH |
Antibodies specifically binding to human il-1r7
|
|
EP3606518A4
(en)
|
2017-04-01 |
2021-04-07 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR DETECTION AND MODULATION OF IMMUNOTHERAPY RESISTANCE GENE SIGNATURE IN CANCER
|
|
KR20210125094A
(ko)
|
2017-04-06 |
2021-10-15 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
비스-링키지를 사용한 세포독성 약물의 접합
|
|
KR20250008984A
(ko)
|
2017-05-18 |
2025-01-16 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
CA3067835A1
(en)
*
|
2017-06-22 |
2018-12-27 |
Apexigen, Inc. |
Anti-vista antibodies and methods of use
|
|
EP3655961A4
(en)
|
2017-07-17 |
2021-09-01 |
Massachusetts Institute of Technology |
HEALTHY AND SICK BARRIER TISSUE CELL ATLAS
|
|
CA3247730A1
(en)
|
2017-11-07 |
2025-10-30 |
Regeneron Pharmaceuticals, Inc. |
Hydrophilic linkers for antibody drug conjugates
|
|
JP7262817B2
(ja)
|
2017-12-31 |
2023-04-24 |
ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ. |
分岐連結体を備えたチューブリシン類縁体の共役体
|
|
WO2019243431A1
(en)
|
2018-06-20 |
2019-12-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions for treating melanoma
|
|
MX2020014083A
(es)
|
2018-07-05 |
2021-04-12 |
Hangzhou Dac Biotech Co Ltd |
Un derivado de dímero de pirrolobenzodiazepina (pbd) reticulado y sus conjugados.
|
|
WO2020046770A1
(en)
|
2018-08-31 |
2020-03-05 |
Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center |
Kinase activity in tumors
|
|
US20230010108A1
(en)
|
2018-10-12 |
2023-01-12 |
Hangzhou Dac Biotech Co., Ltd. |
A conjugation linker containing 2,3-diaminosuccinyl group
|
|
EP3897631A4
(en)
|
2018-12-20 |
2022-11-23 |
C4 Therapeutics, Inc. |
TARGETED PROTEIN BREAKDOWN
|
|
CA3128264A1
(en)
|
2019-01-31 |
2020-08-06 |
Hangzhou Dac Biotech Co., Ltd |
A conjugate of an amanita toxin with branched linkers
|
|
JP2022544442A
(ja)
|
2019-06-24 |
2022-10-19 |
ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ. |
チューブリシン類縁体と細胞結合分子との共役体の製剤
|
|
CA3144784A1
(en)
|
2019-06-24 |
2020-12-30 |
Hangzhou Dac Biotech Co., Ltd |
A conjugate of a cytotoxic agent to a cell binding molecule with branched linkers
|
|
US20230093080A1
(en)
|
2019-07-15 |
2023-03-23 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
EP4053157A4
(en)
|
2019-11-01 |
2023-12-27 |
Cellemedy Co., Ltd |
PROTEIN FUSED WITH A DISEASE ANTIGEN AND CORRESPONDING USE
|
|
JP7541390B2
(ja)
|
2019-11-01 |
2024-08-28 |
セレメディー カンパニー,リミテッド |
免疫チェックポイント分子と結合可能な分子が融合したタンパク質およびその用途
|
|
EP4076526A4
(en)
*
|
2019-12-17 |
2024-07-03 |
The Board Of Regents Of The University Of Texas System |
Novel ddr1 antibodies and uses thereof
|
|
CA3173268A1
(en)
|
2020-02-27 |
2021-09-02 |
Janssen Biotech, Inc. |
Materials and methods for modulating an immune response
|
|
US20210284731A1
(en)
|
2020-03-13 |
2021-09-16 |
Janssen Biotech, Inc. |
Methods and materials for modulating an immune response
|
|
PH12022500032A1
(en)
|
2020-06-19 |
2024-02-26 |
Hangzhou Dac Biotech Co Ltd |
Conjugates of a cell-binding molecule with camptothecin analogs
|
|
IL302037A
(en)
|
2020-10-14 |
2023-06-01 |
C4 Therapeutics Inc |
Tricyclic heterobifunctional compounds for degradation of targeted proteins
|
|
US20230391893A1
(en)
|
2020-10-30 |
2023-12-07 |
Cellemedy Co.,Ltd |
Antibody-like protein and use thereof
|
|
WO2022135332A1
(zh)
|
2020-12-21 |
2022-06-30 |
映恩生物制药(苏州)有限公司 |
一种甾体偶联物
|
|
CN114807042B
(zh)
|
2021-01-22 |
2024-09-03 |
南京助天中科科技发展有限公司 |
一种嵌合抗原受体改造的nk细胞及其制备方法与应用
|
|
WO2022171101A1
(zh)
|
2021-02-10 |
2022-08-18 |
映恩生物制药(苏州)有限公司 |
一种甾体偶联物
|
|
NL2028075B1
(en)
|
2021-04-26 |
2022-11-03 |
Alphathera Ag |
Targeting system for cancer comprising a radioisotope
|
|
US20240216517A1
(en)
|
2021-05-03 |
2024-07-04 |
Cellemedy Co., Ltd |
Pharmaceutical composition for prevention or treatment of lung cancer
|
|
CN119039440A
(zh)
|
2021-07-02 |
2024-11-29 |
来凯医药科技(上海)有限公司 |
活化的肝星状细胞(hsc)的消耗及其用途
|
|
JP2024531480A
(ja)
|
2021-08-26 |
2024-08-29 |
デュアリティ バイオロジクス(スーチョウ)カンパニー,リミティド |
ステロイド化合物及びそのコンジュゲート
|
|
US20250179114A1
(en)
|
2021-09-14 |
2025-06-05 |
Duality Biologics (Suzhou) Co., Ltd. |
Anti-Inflammatory Compound and Use Thereof
|
|
JP2024536840A
(ja)
|
2021-09-26 |
2024-10-08 |
ウーシー バイオロジクス アイルランド リミテッド |
Il-2バリアント及びその融合タンパク質
|
|
WO2023061478A1
(zh)
|
2021-10-15 |
2023-04-20 |
先声再明医药有限公司 |
三环类化合物
|
|
CN117980327A
(zh)
|
2021-11-03 |
2024-05-03 |
杭州多禧生物科技有限公司 |
抗体的特异性偶联
|
|
WO2023163873A1
(en)
|
2022-02-23 |
2023-08-31 |
Mayo Foundation For Medical Education And Research |
Synergistic drug combinations to treat cancer
|
|
WO2023160721A1
(en)
|
2022-02-28 |
2023-08-31 |
Wuxi Biologics (Shanghai) Co., Ltd. |
Heterodimeric polypeptide complexes comprising il-15 variants and uses thereof
|